IBRN P&L Curve

iShares Neuroscience and Healthcare ETF (IBRN) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $5.4M, listed on AMEX, carrying a beta of 0.87 to the broader market. The iShares Neuroscience and Healthcare ETF (IBRN) aims to mirror the financial performance of a particular index. public since 2022-08-24.

A profit/loss curve charts the theoretical gain or loss of an options position across a range of underlying prices. It helps traders visualize risk, identify breakeven points, and compare strategies before committing capital.

Exchange
AMEX
Sector
Financial Services
Industry
Asset Management
Market Cap
$5.4M
IPO Date
2022-08-24
Beta
0.87

As of Nov 13, 2026, the iShares Neuroscience and Healthcare ETF spot price is $34.18; P&L scenarios can be constructed from the options chain. Payoff diagrams should be rebuilt from the live options chain; the preceding values are illustrative and assume a single at-the-money straddle for reference.